DTMH Flashcards
Global burden of dengue
390 million worldwide per year
40-50% of world at risk
70% cases in Asia
Longer and more wet rainy seasons
Cases in Americas rising
Virus of dengue
RNA virus
4 serotypes
3 structural proteins (C, M, E)
7 non-structural proteins (NS)
Process of dengue replication
Binds to receptors
Clarity in mediated endocytosis
Fusion and virus assembly
Viral RNA released into cell
Translation
Viral assembly
Virus maturation
DENV release from cell
Vectors of dengue
Aèdes aegypti:
violin/lyre shaped white markings on thorax
Can bite multiple times
Aedes albopictus
Single silvery white line down thorax
Very adaptable
Clinical manifestations of dengue
incubation 5-7 days
Fever, headache, rashes, muscle pain and joint pain
Rashes of dengue
Initially maculopapular rash
Then petichael rash often at extremities ie ankles
Recovery rash: blanching
Disease phases dengue
febrile phase
Critical period
Recovery phase
Warning signs of dengue
Abdominal pain or tenderness
Persistent vomiting
Clinical fluid accumulation
Mucosal bleed
Lethargy or restlessness
Liver enlargement (2+cm)
Increase in Hct concurrent with drop in Plt count
Definition of acute rheumatic fever
acute multi system, inflammatory process occurring 2-3 weeks after grpA streptococcal pharyngitis
Definition of rheumatic heart disease
chronic process due to scarring of valves during ARF associated with complications such as HF and death
Properties of group A streptococcus
Streptococcus pyogènes, gram positive, beta-haemolytic cocci in chains
Clinical manifestations of streptococcus pyogenes
Superficial: pharyngitis and pyoderma/impetigo
Invasive/toxin mediated:
Skin, soft tissue, lung
Toxic shock syndrome
Necrotising fasciitis
Puerperal sepsis
Scarlet fever
Post infective disease manifestations of group A strep
Rheumatic fever
Syndenham’s chorea
RHD
Acute glomerulonephritis
Global burden of group A strep
33mill worldwide prevalence estimates from echo screening and/or from HF/stroke/arrhythmias/pregnancy related complication data
Clinical features of group A strep infection
Children aged 5-15 years
Joint pain (migratory, large joint)
Carditis (mitral first)
Chorea
Incubation: 10-14days following GAS pharyngitis
Drivers of rheumatic heart disease
Group a streptococcus is the trigger but
Kids affected - lack of immunity
Pathogenesis poorly understood
Issues with molecular mimicry - affects vaccine development
Frequency of GrpA strep infections affecting moving on to rheumatic fever - ie poverty/environments can mean some kids are exposed to over 5 different types which then drives up risk, whereas in UK may be much less
Criteria for RHD
Low risk countries
JONES 2015 in low risk
Major:
Carditis
Arthritis - poly
Chorea
Subcutaneous nodules
Erythema marginatum
Minor
Polyarthralgia
Fever 38.5+
ESR 60+/CRP 30+
Prolonged PR
Criteria for RHD
High risk countries
JONES 2015 in high risk
Major:
Carditis
Arthritis - poly or mono, polyarthralgia
Chorea
Subcutaneous nodules
Erythema marginatum
Minor
Monoarthralgia
Fever 38.0+
ESR 60+/CRP 30+
Prolonged PR
How to diagnose Rheumatic fever?
Evidence of Strep A plus
2x major criteria
1x major and 2x minor
From Jones criteria 2015
How to confirm Rheumatic fever?
- Evidence of Strep A:
a. Swab, serology, rapid test (except for chorea & indolent carditis)- Serologic tests
a. ASO & ADB - rising titre
b. Variable availability and normal ranges
- Serologic tests
Diagnosis?
- 7year old girl presents to health centre with SOB + left knee pain + abdominal pain, biventricular failure on CXR, tender gross hepatomegaly, died of cardiogenic shock
RHD
Spooning / milkmaids grip a clinical feature of…
Chorea associated with RHD
Management of rheumatic fever
Acute mx:
1. Patient/family education
2. Single dose BenPen or otherwise oral pen or erythromycin if pen allergic
3. Analgesia +/- NSAIDs
4. Diuresis, ACEi, +/- steroids
Longer term management of rheumatic heart disease
Longer term:
1. Prevent recurrence (including sub clinical)
○ Secondary prophylaxis for prevention of ARF = secondary prevention
2. Manage HF
3. Anti coagulation for AF or valve replacement
4. Assessment for intervention/surgery